Pure Biologics (WAR:PUR) Long-Term Debt : zł0.00 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Pure Biologics Long-Term Debt?

Pure Biologics's Long-Term Debt for the quarter that ended in Sep. 2024 was zł0.00 Mil.

Pure Biologics's quarterly Long-Term Debt declined from Mar. 2024 (zł13.02 Mil) to Jun. 2024 (zł0.00 Mil) but then stayed the same from Jun. 2024 (zł0.00 Mil) to Sep. 2024 (zł0.00 Mil).

Pure Biologics's annual Long-Term Debt stayed the same from Dec. 2021 (zł0.00 Mil) to Dec. 2022 (zł0.00 Mil) but then increased from Dec. 2022 (zł0.00 Mil) to Dec. 2023 (zł12.72 Mil).

Pure Biologics Long-Term Debt Historical Data

The historical data trend for Pure Biologics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pure Biologics Long-Term Debt Chart

Pure Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

12.72

Pure Biologics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Debt	Get a 7-Day Free Trial															12.33	12.72	13.02	-	-

Pure Biologics (WAR:PUR) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Pure Biologics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Pure Biologics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Pure Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pure Biologics SA (WAR:PUR) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Dunska 11, Wroclaw, POL, 54-427

Website

http://www.purebiologics.pl

Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.

Pure Biologics Headlines

No Headlines